Skip to main content
Log in

Tyrosinemia type I: A clinico-laboratory case report

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Progressive hepatocellular dysfunction in a neonate, resulting in elevated serum α-fetoprotein together with raised blood levels of tyrosine and methionine, a generalized amino aciduria and the absence of urinary δ-aminolevulinic acid and succinylacetone, suggests a diagnosis of tyrosinemia type Ib. Classical tyrosinemia type I arises from a deficiency of fumarylacetoacetate hydrolase while the variant tyrosinemia type Ib results from a deficiency of maleylacetoacetate isomerase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lindblad B, Lindstedt S, Steen G. On the enzymatic defects in hereditary tyrosinemia.Proc Natl Acad Sci (USA) 1977; 74: 4641–4645.

    Article  CAS  Google Scholar 

  2. St-Louis M, Tanguay RM. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I. Overview.Hum Mutat 1997; 9: 291.

    Article  PubMed  CAS  Google Scholar 

  3. De Brackeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada)Hum Hered 1991; 41:141.

    Article  Google Scholar 

  4. Kvittingen E. Hereditary tyrosinemai type I — an overview.Scand J Clin Lab Invest 1986; 46:27–34.

    Article  CAS  Google Scholar 

  5. Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type I.Seminars in Liver Disease 2001; 21: 563–571.

    Article  PubMed  CAS  Google Scholar 

  6. Mitchell GA, Larochelle J, Lambert Met al. Neurologic crisis in hereditary tyrosinemia.N Engl J Med 1990; 322:432–437.

    Article  PubMed  CAS  Google Scholar 

  7. Krywawych S. Thin layer chromatography of non-volatile organic acids in clinical chemistry.Clin Chem Acta 1979; 91:353–361.

    Article  CAS  Google Scholar 

  8. Grenier A, Lescault A, Laberge C, Gagne R, Mamer O. Detection of succinylacetone and use of its measurement in mass screening for hereditary tyrosinemia.Clin Chem Acta 1982; 123:93–99.

    Article  CAS  Google Scholar 

  9. Mitchell G, Grompe M, Lambert M, Tanguay RM. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic and Molecular Bases of Inherited Disease. Chapter 79, Vol II pp 1777–1805 8th edn. New York. McGraw-Hill.

  10. Mitchell GA, Russo PA, Dubois J, Alvarez F. In Suchy FJ, Sokol J, Balistreri WF, eds.Tyrosinemia, Chapter 29, Liver Disease in Children. 2nd edn. Phiadelphia, Lippincott Williams & Wilkins, (2001).

    Google Scholar 

  11. Berger R, Michals K, Galbraeth J, Matalon R. Tyrosinemia type Ib caused by malylacetoacetate isomerase deficiency: a new enzyme defect.Pediatr Res 1988; 23:328A.

    Google Scholar 

  12. Holme E, Lindstedt S. Tyrosinemia type 1 and NTBC (2(2-nitro-4-trifluoro-methylbenzyol)-1,3 cyclohexanedione).J Inherit Metab Dis 1998; 21: 507–517.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Oommen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karnik, D., Thomas, N., Eapen, C.E. et al. Tyrosinemia type I: A clinico-laboratory case report. Indian J Pediatr 71, 929–932 (2004). https://doi.org/10.1007/BF02830839

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02830839

Key words

Navigation